Literature DB >> 15351828

Asymmetric total synthesis of sperabillins B and D via lithium amide conjugate addition.

Stephen G Davies1, Jane R Haggitt, Osamu Ichihara, Richard J Kelly, Michael A Leech, Anne J Price Mortimer, Paul M Roberts, Andrew D Smith.   

Abstract

Diastereoselective conjugate addition of homochiral lithium (R)-N-allyl-N-alpha-methylbenzylamide to methyl (2E,5E)-hepatadienoate, followed by protecting group manipulation and subsequent iodocyclocarbamation allows a concise route to the core fragment, methyl (3R,5R,6R)-3,6-diamino-5-hydroxyheptanoate, of sperabillins B and D. Differentiation between the C-3 and C-6 primary amino groups of this core amino acid was readily achieved by treatment with acetone, giving the 5,6-isopropylidene and C-3-imine protected diamine, with subsequent regioselective acylation of the C-6-nitrogen facilitating the total synthesis of sperabillin D in 10.8% overall yield, and the first asymmetric synthesis of sperabillin B in 5.8% overall yield.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351828     DOI: 10.1039/B404962D

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Development of chiral fluorinated alkyl derivatives of emixustat as drug candidates for the treatment of retinal degenerative diseases.

Authors:  Eliav Blum; Jianye Zhang; Edward Korshin; Krzysztof Palczewski; Arie Gruzman
Journal:  Bioorg Med Chem Lett       Date:  2020-07-18       Impact factor: 2.823

2.  Formal synthesis of salinosporamide A via NHC-catalyzed intramolecular lactonization.

Authors:  Justin R Struble; Jeffrey W Bode
Journal:  Tetrahedron       Date:  2009-06-27       Impact factor: 2.457

3.  Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy.

Authors:  Eliav Blum; Jianye Zhang; Jordan Zaluski; David E Einstein; Edward E Korshin; Adam Kubas; Arie Gruzman; Gregory P Tochtrop; Philip D Kiser; Krzysztof Palczewski
Journal:  J Med Chem       Date:  2021-06-03       Impact factor: 8.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.